Details
OM Pharma is a Swiss pharmaceutical company focused on the development, manufacturing, and commercialization of immunotherapies and prescription medicines, particularly in the areas of respiratory health, infectious diseases, and immune system support.
The company is best known for its bacterial lysate-based immunotherapy products, which are designed to help strengthen the immune system and reduce the frequency of respiratory tract infections. These treatments are widely used in preventive healthcare and clinical settings.
OM Pharma operates as part of the global pharmaceutical industry, working with healthcare professionals, hospitals, and pharmacies to provide therapeutic solutions that address both acute and chronic conditions. It combines research, pharmaceutical manufacturing, and medical expertise to develop evidence-based treatments.
The company has a strong presence in Europe and other international markets, and it focuses on innovation in immunology and respiratory medicine. Its work is centred on improving patient outcomes through preventive and therapeutic healthcare solutions.